Survey of 239 patients suggests CBG may benefit pain, sleep and anxiety by Adam Sheldon March 9, 2026March 10, 2026 New real-world data has suggested the minor cannabinoid CBG may improve pain, sleep and anxiety at […]
Avecho prepares for potentially ‘transformative’ CBD trial results by Adam Sheldon March 4, 2026March 5, 2026
Study traces how cannabis developed the ability to produce cannabinoids by Adam Sheldon January 13, 2026January 13, 2026
News in brief: Avecho gains key patent allowances; Montu expands medical affairs team by Adam Sheldon December 9, 2025February 21, 2026
Financial news in brief: Elixinol addresses funding concerns; Aurora growth helped by Australia; Avecho lifts cash, progresses trial; Cann receives NAB extension to finalise settlement; IRX reports lean quarter by Adam Sheldon November 4, 2025February 21, 2026
Trump CBD video sparks US stock rally – and hope among local firms by Adam Sheldon October 1, 2025October 1, 2025
Humacology reports promising outcomes from women’s health and PTSD studies by Adam Sheldon September 23, 2025February 21, 2026
News in brief: Losses widen for Avecho and Elixinol; InhaleRx secures HREC approval; Zelira cuts deficit; Argent shifts from ‘non-core’ activities by Adam Sheldon August 29, 2025February 21, 2026
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
University of SA researchers develop new solution to improve bioavailability of CBD by cannabiz team March 20, 2025April 4, 2025
